Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Myeloid 1Lymphoid 1

Conditions

Lymphoma, Non-Hodgkin 1Lymphohistiocytosis, Hemophagocytic 1

Interventions

Etoposide 5pegaspargase 4Dexamethasone 3Methylprednisolone 2Gemcitabine 2Doxorubicin 2sintilimab 1ruxolitinib 1Vincristine 1Th1-Th2 Balance 1Prednisone 1N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 1EPOCH protocol 1Cyclophosphamide 1Cisplatin 1Azacitidine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Lymphohistiocytosis, Hemophagocytic × EPOCH protocol × Clear all
NCT01818908 2019-02-15

Trial of DA-EPOCH Regimen for NHL With HLH

The First Affiliated Hospital with Nanjing Medical University

Phase 2 Unknown
50 enrolled
LymphoidMyeloid

Lymphoma, Non-Hodgkin, Lymphohistiocytosis, Hemophagocytic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡